Page last updated: 2024-10-27

flumazenil and Venous Thrombosis

flumazenil has been researched along with Venous Thrombosis in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.

Research Excerpts

ExcerptRelevanceReference
"Besides modifiable risk factors, genetic susceptibility may also explain the high cardiovascular disease burden of the Roma population."1.51Genetic profiling revealed an increased risk of venous thrombosis in the Hungarian Roma population. ( Ádány, R; Fiatal, S; Kósa, Z; Pikó, P; Sándor, J, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiatal, S1
Pikó, P1
Kósa, Z1
Sándor, J1
Ádány, R1

Other Studies

1 other study available for flumazenil and Venous Thrombosis

ArticleYear
Genetic profiling revealed an increased risk of venous thrombosis in the Hungarian Roma population.
    Thrombosis research, 2019, Volume: 179

    Topics: Adult; Cardiovascular Diseases; Female; Genetic Predisposition to Disease; Humans; Hungary; Male; Mi

2019